This week addressed AI accountability, CPHI award winners, NFC anticounterfeiting, first-in-class FDA approvals, and a shelved FDA voucher pilot lead this week’s roundup.
|Articles|April 26, 2016
Overcoming Bottlenecks in Biopharmaceutical Development
Advertisement
Keynote SeriesPharmaceutical Technology and BioPharm International are sponsoring a Keynote Series discussion on bioprocessing challenges on the INTERPHEX 2016 Exhibit Hall Innovation Stage. Admission is free to any attendee with an exhibit hall pass.
Tuesday, April 26, 10:15 am to 11:45 am
Overcoming Bottlenecks in Biopharmaceutical Development
In a panel discussion, industry experts will discuss how technology advances are addressing challenges in biopharmaceutical development including quality control of raw materials, implementation of single-use technologies, process monitoring, and downstream purification.
Panelists:
Marian L. McKee, PhD, Director, US Development Services, MilliporeSigma
Mike Goodwin, Director of R&D, SUT, Thermo Fisher Scientific
Alex Perieteanu, PhD, Director, Biopharmaceutical Services - Life Sciences, SGS Mississauga
Elizabeth Goodrich, Director of Applications Engineering, MilliporeSigma
To register:
Advertisement
Related to this article
Cole and Jaenisch explain why defending against AI poisoning in pharma manufacturing calls for a data steward role, immutable instruction ledgers, and automation.
Gloveless isolators don’t end interventions. Learn to assess intervention dependency in robotic aseptic filling and when glove ports are justified.
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how the company’s product is worth the investment by protecting products and patients.
The FDA has shelved its National Priority Voucher pilot, leaving sponsors that built CMC and launch-readiness plans around 1- to 2-month reviews facing uncertain timelines.
Regulators will test pharma companies against their own internal AI policies. Jaenisch, Muraru, and Pandey explain how to build defensible, inspection-ready AI practices.
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how its connected technology can enhance anticounterfeiting and how data are handled within the product.
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
France Remains One of Europe’s Leading Biotech Funding Hubs
2
The Impact of Excipients on Continuous Manufacturing and the Risk of Nitrites
3
CPHI Milan Future Leader Award Winner: Pauline van der Wijst-Janssen
4
PharmTech’s Weekly Roundup—November 6, 2026: Impurities, Supply Resilience, and AI Accountability
5